The Chemical Biological Medical Systems – Biosurveillance (CBMS-BSV) office of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) will host an Industry Day on April 3-4, 2012 in Memphis, Tennessee to discuss the Next Generation Diagnostics System (NGDS) sourcing initiative.
CBMS-BSV is preparing to issue a Request for Proposals (RFP) for Commercial Off-The-Shelf (COTS) systems for the NGDS Increment 1 program. This incremental acquisition is intended to provide FDA-cleared diagnostic capabilities for CBRN threats and emerging threats of operational concern. The anticipated strategy for NGDS is to develop, test and field an initial FDA-cleared CBRN diagnostic capability and to add additional FDA-cleared assays over a 4-year period. The program is also interested in enabling technologies to enhance patient screening and collection and transport of clinical samples for diagnostic analysis.
The NGDS Increment 1 is intended to eventually replace the current Joint Biological Agent Identification and Diagnostic System (JBAIDS). The government has empasized the ability of the device to integrate with DoD CBRN and medical information systems to further enable timely diagnosis and treatment as well providing battle field commanders with biological hazard situational awareness to support Force Protection decision making.
Detailed contract requirements for NGDS Soliciation W911QY12R0021 will be released as a draft Request for Proposal (RFP) on March 20, 2012 here (link inactive until release date).
Contractors wishing to attend the Industry Day must register no later than 3:00 p.m. (Eastern) on March 30, 2012. Contractors will be offered the opportunity to schedule one-on-one meetings with the Government during the registration process.
